- Home
- STKS vs ANIX Comparison
STKS vs ANIX Comparison
Compare STKS & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STKS
- ANIX
- Stock Information
- Founded
- STKS 2004
- ANIX 1982
- Country
- STKS United States
- ANIX United States
- Employees
- STKS N/A
- ANIX N/A
- Industry
- STKS Restaurants
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- STKS Consumer Discretionary
- ANIX Health Care
- Exchange
- STKS Nasdaq
- ANIX Nasdaq
- Market Cap
- STKS 109.7M
- ANIX 95.7M
- IPO Year
- STKS N/A
- ANIX 1987
- Fundamental
- Price
- STKS $2.64
- ANIX $3.52
- Analyst Decision
- STKS Hold
- ANIX Strong Buy
- Analyst Count
- STKS 3
- ANIX 3
- Target Price
- STKS $4.50
- ANIX $9.00
- AVG Volume (30 Days)
- STKS 65.1K
- ANIX 85.5K
- Earning Date
- STKS 11-06-2025
- ANIX 09-10-2025
- Dividend Yield
- STKS N/A
- ANIX N/A
- EPS Growth
- STKS N/A
- ANIX N/A
- EPS
- STKS N/A
- ANIX N/A
- Revenue
- STKS $834,363,000.00
- ANIX N/A
- Revenue This Year
- STKS $26.58
- ANIX N/A
- Revenue Next Year
- STKS $5.37
- ANIX N/A
- P/E Ratio
- STKS N/A
- ANIX N/A
- Revenue Growth
- STKS 96.64
- ANIX N/A
- 52 Week Low
- STKS $2.37
- ANIX $2.07
- 52 Week High
- STKS $5.26
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- STKS 36.93
- ANIX 71.33
- Support Level
- STKS $2.43
- ANIX $2.93
- Resistance Level
- STKS $2.80
- ANIX $3.09
- Average True Range (ATR)
- STKS 0.12
- ANIX 0.14
- MACD
- STKS 0.02
- ANIX 0.04
- Stochastic Oscillator
- STKS 42.00
- ANIX 96.72
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.